证券代码：301009 证券简称：可靠股份 杭州可靠护理用品股份有限公司投资者关系活动记录表 编号：2025-001 投资者关系活 动类别 □特定对象调研 □分析师会议 媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 其他 （电话会议、线上会议） 参与单位名称 及人员姓名 2025 年 1 月 24 日 10:00-11:00：天风证券：孙海洋、张彤；泰康资产： 蒋雪莹、王琦、蒋友松；阳光资管：吴彬；上海混沌投资：黎晓楠；财 通资管：赵雯；泰康基金：刘书琴；工银：何睿豪；银河基金：杨琪；中 国国际金融：袁咪；上海五聚资管：王鑫；前海云溪基金：李志勇；循 远资管：田超平；广东正圆投资：亓辰；上海泾溪投资：柯伟；德懿禾 资管：赵哲锐；上海原泽私募基金：姚珊；创金合信基金：梁雪；上海 煜德投资：程跃；北京诚盛投资：完永东 2025 年 1 月 24 日 11:00-12:00：西南证券：蔡欣、沈琪 时间 2025年1月24日 10:00-11:00；11:00-12:00 地点 电话会议、线上会议 上市公司参与 人员姓名 副总经理兼财务总监：李超楠 资本运营总监：王向亭 证券投资经理兼证券事务代表：周 ...

Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [5]. Core Insights - The company is expected to turn profitable in Q4 2024, with a projected net profit of 0.26-0.34 billion yuan, representing a year-on-year increase of 29-68% [1]. - The adult incontinence products market in China is experiencing increasing penetration rates, driven by government support for elderly care and the expansion of long-term care insurance [2]. - The company plans to enhance its self-owned brands and product offerings, focusing on cost reduction and efficiency improvements to drive stable growth [3]. - The financial forecast has been adjusted upwards, with expected revenues of 1.07 billion, 1.16 billion, and 1.3 billion yuan for 2024, 2025, and 2026 respectively, alongside net profits of 0.32 billion, 0.39 billion, and 0.46 billion yuan [4]. Summary by Sections Financial Performance - The company anticipates a net profit of 0.04-0.12 billion yuan in Q4 2024, compared to a loss of 0.007 billion yuan in Q4 2023 [1]. - The 2024 forecasted net profit after deducting non-recurring items is estimated at 0.03-0.12 billion yuan, improving from a loss of 0.008 billion yuan in the previous year [1]. - The company’s revenue for 2024 is projected to be 1.067 billion yuan, with a slight decline from 2023, but expected to grow in subsequent years [9]. Market Trends - The adult incontinence products market is set to grow due to increased government focus on elderly care and the expansion of long-term care insurance, with over 1.8 billion people insured in pilot cities [2]. - The company is positioned to benefit from the growing demand for elderly care products as the aging population increases [2]. Brand Strategy - The company is focusing on its self-owned brands such as "Reliable," "Absorbent Treasure," and "An Nurse," aiming to enhance brand recognition and market position [3]. - Plans include increasing R&D investment, accelerating product innovation, and expanding both online and offline distribution channels [3].

Financial Performance Expectations - The company expects a net profit attributable to shareholders of between 26 million and 34 million RMB, representing a year-on-year increase of 28.81% to 68.44%[3] - The net profit after deducting non-recurring losses is projected to be between 20 million and 29 million RMB, reflecting a year-on-year growth of 10.57% to 60.32%[3] Factors Influencing Performance - The increase in operating performance is attributed to cost reduction efforts and a slight decrease in raw material prices, leading to an improvement in gross margin[5] - Exchange rate fluctuations have resulted in increased foreign exchange gains compared to the same period last year[5] - Non-recurring gains and losses are estimated to impact net profit by approximately 5 million to 6 million RMB, primarily from other income and investment income[7] Financial Reporting and Risks - The financial data in the earnings forecast has not been audited by a registered accounting firm[4] - The specific data for the 2024 annual performance will be detailed in the 2024 Annual Report[8] - The company emphasizes the importance of cautious decision-making and awareness of investment risks for investors[8]

证券代码：301009 证券简称：可靠股份 公告编号：2024-074 杭州可靠护理用品股份有限公司董事会 2024 年 12 月 27 日 1 杭州可靠护理用品股份有限公司（以下简称"公司"）及控股子公司杭州可 艾个人护理用品有限公司（以下简称"杭州可艾公司"）根据全国高新技术企业 认定管理工作领导小组办公室近日发布的《对浙江省认定机构 2024 年认定报备 的高新技术企业进行备案的公告》获悉，公司及控股子公司杭州可艾公司已通过 高新技术企业重新认定，证书编号分别为 GR202433002992、GR202433004571，发 证日期为 2024 年 12 月 6 日，有效期为三年。 本次认定系公司及控股子公司杭州可艾公司原高新技术企业证书有效期满 后进行的重新认定。根据《中华人民共和国企业所得税法》等相关规定，公司及 控股子公司杭州可艾公司自本次通过高新技术企业重新认定后连续三年（2024 年至 2026 年）享受国家关于高新技术企业的相关税收优惠政策，即按 15%的税 率缴纳企业所得税。该税收优惠政策不会对公司本年度业绩产生重大影响。 特此公告。 杭州可靠护理用品股份有限公司 关于公司及控股子公司通过 ...

国泰君安证券股份有限公司 关于杭州可靠护理用品股份有限公司 2024年度持续督导定期现场检查报告 保荐机构名称：国泰君安证券股份有限公司 被保荐公司简称：可靠股份 保荐代表人姓名：陈圳寅 联系电话：010-83939236 保荐代表人姓名：庞燎源 联系电话：010-83939239 现场检查人员姓名：陈圳寅、庞燎源、田晓雨 现场检查对应期间：2024年度 现场检查时间：2024年12月10日至2024年12月11日 一、现场检查事项 现场检查意见 是 否 不适用 （一）公司治理 现场检查手段：查阅《公司章程》及相关制度性文件、三会资料及重大经营活 动决策文件；查阅公司及控股股东、实际控制人的信息披露文件；对公司主要 负责人及有关人员进行访谈。 1.公司章程和公司治理制度是否完备、合规 √ 2.公司章程和三会规则是否得到有效执行 √ 3.三会会议记录是否完整，时间、地点、出席 人员及会议内容等要件是否齐备，会议资料是 否保存完整 √ 4.三会会议决议是否由出席会议的相关人员签 名确认 √注1 5.公司董监高是否按照有关法律、行政法规、 部门规章、规范性文件和本所相关业务规则履 行职责 √ 6.公司董监高如发生重 ...

根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市 规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》《上市公 司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修订）》 等法律法规的要求，本次培训主要内容为上市公司规范运作要点、并购重组市场 介绍以及近期上市公司处罚案例等。 保荐人本次持续督导培训的工作过程中，公司积极予以配合，保证了培训工 作的有序进行，达到了良好效果。 国泰君安证券股份有限公司 关于杭州可靠护理用品股份有限公司 2024年度持续督导培训情况报告 根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市 规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等相关要 求，国泰君安证券股份有限公司（以下简称"国泰君安"）作为杭州可靠护理用 品股份有限公司（以下简称"可靠股份"或"公司"）首次公开发行股票并在创 业板上市的持续督导机构，于 2024 年 12 月 ...

证券代码：301009 证券简称：可靠股份 公告编号：2024-073 杭州可靠护理用品股份有限公司 关于公司股价异动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 4、公司及控股股东、实际控制人均不存在关于本公司应披露而未披露的重 大事项，或处于筹划阶段的重大事项。 5、股票异常波动期间，公司控股股东、实际控制人及公司董事、监事、高 级管理人员不存在买卖公司股票的情形。 三、是否存在应披露而未披露信息的说明 公司董事会确认，本公司目前没有任何根据《深圳证券交易所创业板股票上 市规则》等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、 一、股票交易异常波动的情况 杭州可靠护理用品股份有限公司（以下简称"公司"或"本公司"）股票（证 券简称：可靠股份；证券代码：301009）于 2024 年 12 月 16 日、2024 年 12 月 17 日连续两个交易日收盘价格涨幅偏离值累计超过 30%，根据深圳证券交易所相 关规定，属于股票交易异常波动的情形。 二、公司关注并核实情况的说明 针对公司股票交易异常波动情况，公司董事会采用通讯结合现场问询的 ...

证券代码：301009 证券简称：可靠股份 公告编号：2024-072 联系地址：浙江省杭州市临安区锦城街道（城西工业园）花桥路 2 号 电话：0571-63702088 传真：0571-63702088 杭州可靠护理用品股份有限公司 关于副总经理、董事会秘书辞职暨董事长代行董事会 秘书职责的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 杭州可靠护理用品股份有限公司（以下简称"公司"）董事会于近日收到副 总经理、董事会秘书谢丽红女士递交的书面辞职报告，谢丽红女士因个人原因向 董事会申请辞去公司副总经理、董事会秘书职务，辞职后将不在公司担任其他职 务，谢丽红女士的辞职申请自送达公司董事会之日起生效，其辞职不会影响公司 的日常生产经营的开展。 谢丽红女士的原定任期为 2024 年 1 月 19 日至公司第五届董事会届满之日 止。截至本公告披露日，谢丽红女士未直接或间接持有公司股份，亦不存在应当 履行而未履行的承诺事项。公司董事会对谢丽红女士在任职期间为公司所作出的 贡献表示衷心的感谢。 为保障公司治理及信息披露事务正常开展，在董事会秘书空缺期间，根据《深 ...

杭州可靠护理用品股份有限公司（以下简称"公司"）于 2024 年 3 月 1 日 召开了第五届董事会第二次（临时）会议、第五届监事会第二次（临时）会议， 审议通过了《关于回购股份方案的议案》，同意公司使用自有资金以集中竞价方 式回购公司已发行的人民币普通股（A 股）股票，回购的股份将用于实施员工持 股计划或股权激励。本次回购的资金总额不低于人民币 3,000 万元且不超过人民 币 5,000 万元（均含本数），回购股份价格不超过人民币 13 元/股（含本数）， 回购实施期限自董事会审议通过本次回购方案之日起不超过 12 个月。具体内容 详见公司分别于 2024 年 3 月 4 日、2024 年 3 月 6 日在巨潮资讯网披露的《关于 回购股份方案的公告》（公告编号：2024-018）、《回购报告书》（公告编号： 2024-019）。 因公司实施 2023 年度权益分派，权益分派后公司回购股份价格上限将由 13 元/股调整为 12.93 元/股，回购股份价格上限调整生效时间为自 2024 年 7 月 19 日，具体内容详见公司于 2024 年 7 月 12 日在巨潮资讯网披露的《关于 2023 年 度权益分派后 ...

Revenue and Profit - Revenue for Q3 2024 reached ¥268,233,969.83, an increase of 9.86% compared to the same period last year[2] - Net profit attributable to shareholders was a loss of ¥1,144,005.49, a decrease of 121.51% year-on-year[2] - Total operating revenue for Q3 2024 was approximately CNY 789.11 million, a decrease of 2.06% from CNY 806.77 million in Q3 2023[18] - Net profit for Q3 2024 was CNY 21.98 million, a decline of 14.9% compared to CNY 25.84 million in Q3 2023[19] - Total comprehensive income for the period attributable to the parent company was CNY 22,073,000.56, down 18.9% from CNY 27,197,529.21 in the previous period[20] - Basic and diluted earnings per share decreased to CNY 0.0819 from CNY 0.1001, representing a decline of 18.2%[20] Cash Flow and Investments - Cash flow from operating activities for the year-to-date was ¥37,968,489.31, down 76.55% compared to the previous year[9] - Cash inflow from operating activities totaled CNY 927,738,782.40, a decrease of 7.7% compared to CNY 1,005,738,487.76 in the previous period[22] - Net cash flow from operating activities was CNY 37,968,489.31, significantly down from CNY 161,915,638.19 in the previous period, reflecting a decline of 76.6%[22] - Cash outflow from investing activities amounted to CNY 807,968,440.30, compared to CNY 65,606,331.26 in the previous period, indicating a substantial increase in investment expenditures[22] - Net cash flow from investing activities was negative at CNY -247,698,015.22, worsening from CNY -62,580,376.26 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,919,360,200.81, a decrease of 3.65% from the end of the previous year[2] - The company's total assets amounted to CNY 1.92 billion, a decrease from CNY 1.99 billion at the end of Q3 2023[17] - Current liabilities totaled CNY 445.11 million, down from CNY 485.30 million in the previous year[17] - Non-current liabilities decreased to CNY 52.70 million from CNY 57.10 million year-over-year[17] - The company’s total equity attributable to shareholders decreased to ¥1,344,571,778.47, down 2.05% from the previous year[2] - The total equity attributable to shareholders of the parent company was CNY 1.34 billion, down from CNY 1.37 billion in Q3 2023[17] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,039, with the largest shareholder, Jin Liwei, holding 30.13% of shares (81,909,282 shares) [10] - The company repurchased a total of 5,435,800 shares, accounting for 2.00% of the total share capital, with a total transaction amount of RMB 49,689,136 [14] - The total number of shares held by the top ten shareholders includes significant stakes from Jin Liwei and Bao Jia, who together hold over 59% of the company [10] - The company’s total limited shares at the end of the period is 141,302,293 shares, with a significant portion being executive locked shares [12] Expenses and Other Income - The company reported a significant increase in sales expenses, totaling ¥94,602,314.55, up 37.57% year-on-year due to increased marketing efforts[7] - Research and development expenses for Q3 2024 were CNY 32.86 million, slightly down from CNY 33.24 million in Q3 2023[19] - The company reported a significant increase in other income, totaling ¥2,430,528.57, up 1069.40% year-on-year[8] Inventory and Receivables - The company’s inventory increased from RMB 114,820,040.22 to RMB 126,686,960.12 during the reporting period [15] - The company’s accounts receivable decreased from RMB 193,282,289.99 to RMB 172,099,008.19 during the reporting period [15] - The company’s prepayment increased from RMB 6,220,402.57 to RMB 17,097,992.04 during the reporting period [15] Cash and Cash Equivalents - The company’s cash and cash equivalents decreased from RMB 863,061,836.17 at the beginning of the period to RMB 588,399,193.59 at the end of the period [15] - Cash and cash equivalents at the end of the period decreased to CNY 531,134,102.01 from CNY 731,733,172.89, a decline of 27.4%[22]